A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis
Clinical trial NCT06451159 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06451159
- Sponsor
- Bruce Cree
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2026-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.